Fundraising Fox

Spero Therapeutics

NASDAQ: SPRO

Cambridge, US · Founded 2013 · Delaware corporation · 5 known investors

Biotechin /spero-therapeutics

Founders & leadership

PV
Patrick VinkDirector
MD
Milind DeshpandeDirector
JF
Jean-Francois FormelaDirector
RH
Reza HalseDirector
CB
Casper BreumDirector
AM
Ankit MahadeviaExecutive Officer, Director
SG
Stephen GarbaczExecutive Officer
VG
Vikas GoyalDirector

Investors · 5

HEALTHCARE ROYALTY PARTNERSNew York
MRL Ventures FundCambridge · $25M
OUP (Osage University Partners)Bala Cynwyd · $1M – $20M
RA CapitalBostonvia Reza Halse · board
Atlas VenturereportedCambridge · $500K – $1Mvia Jean-François Formela · board

Reported raises · per SEC filings

Form D private placements
▶$9MraisedNov 2022 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Milind DeshpandeDirector
  • Kamal HamedExecutive Officer
  • Scott JacksonDirector
  • Tamara JosephExecutive Officer
  • Kathleen TregoningDirector
  • Patrick VinkDirector
  • Satyavrat ShuklaExecutive Officer
  • Timothy KeutzerExecutive Officer
  • John C. Pottage, Jr.Director
  • Ankit MahadeviaExecutive Officer, Director
  • Cynthia SmithDirector
  • Frank E. ThomasDirector
Offering amount
$9M
Amount sold
$9M
First sale
Nov 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$40MraisedJul 2021 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Milind DeshpandeDirector
  • David MelnickExecutive Officer
  • Patrick VinkDirector
  • Cynthia SmithDirector
  • Satyavrat ShuklaExecutive Officer
  • Tamara JosephExecutive Officer
  • Scott JacksonDirector
  • Timothy KeutzerExecutive Officer
  • Frank E. ThomasDirector
  • Cristina LarkinExecutive Officer
  • John C. Pottage, Jr.Director
  • Ankit MahadeviaExecutive Officer, Director
  • Jean-Francois FormelaDirector
Offering amount
$40M
Amount sold
$40M
First sale
Jun 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$43.2MraisedMar 2017 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Patrick VinkDirector
  • Milind DeshpandeDirector
  • Jean-Francois FormelaDirector
  • Reza HalseDirector
  • Casper BreumDirector
  • Ankit MahadeviaExecutive Officer, Director
  • Stephen GarbaczExecutive Officer
  • Vikas GoyalDirector
Offering amount
$43.2M
Amount sold
$43.2M
First sale
Mar 2017
Incorporated
Limited Liability Company, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.